01/23/2012 - 12:49pm

Avian flu researchers have agreed to take a 60-day hiatus on testing an H5N1 influenza strain that recently had gained public attention, according to a letter published Friday in the journal Science.

01/23/2012 - 10:56am

A panel of experts at the Food and Drug Administration has declined to recommend approval for a topical drug for preventing premature birth in pregnant women, the drug's manufacturers said.

01/20/2012 - 5:33pm

With the patent cliff and subsequent innovation drought moving closer, generic drug makers are looking to move up the value chain and pursue new sources of revenue, and of all the piles of pay dirt out there, biosimilars represent one of the closest things to an El Dorado, though regulations won’t take their final form for a while.


01/20/2012 - 5:33pm

It has become a perennial issue, and one that is likely to crop up at least once this year: patent settlements.


01/20/2012 - 5:33pm

If the patent cliff were a sports team, Pfizer’s cholesterol-
lowering drug Lipitor (atorvastatin) would be its mascot.

01/20/2012 - 5:33pm

For all the talk about generic drugs and their potential to save piles of money for the country’s healthcare system, it’s going to be a while before many of them actually reach consumers because of the Food and Drug Administration’s huge backlog of generic drug regulatory approval applications.


01/20/2012 - 5:32pm

One issue that is unlikely to see resolution this year is the growing problem of drug shortages. As of October 2011, the Food and Drug Administration and the American Society of Health Systems Pharmacists found shortages of 168 drugs.

01/20/2012 - 5:32pm

In the Feb. 7, 2011, issue, Drug Store News named three major issues that would define 2011 for the world of generic drugs. Those issues were drug safety, generic user fees and patent settlements.

01/20/2012 - 10:46am

Drug maker Bristol-Myers Squibb has donated $6.9 million to a nonprofit group that helps people pay for medical treatments, the company said.